Skip to Content

44 503 (Cold Multi-Symptom Severe acetaminophen 325 mg / dextromethorphan 10 mg / guaifenesin 200 mg / phenylephrine 5 mg)

Generic Name: acetaminophen/dextromethorphan/guaifenesin/phenylephrine

Pill with imprint 44 503 is Yellow, Capsule-shape and has been identified as Cold Multi-Symptom Severe acetaminophen 325 mg / dextromethorphan 10 mg / guaifenesin 200 mg / phenylephrine 5 mg. It is supplied by Stephen L. LaFrance Pharmacy, Inc..

Cold Multi-Symptom Severe is used in the treatment of cold symptoms; influenza and belongs to the drug class upper respiratory combinations. FDA has not classified the drug for risk during pregnancy. Cold Multi-Symptom Severe acetaminophen 325 mg / dextromethorphan 10 mg / guaifenesin 200 mg / phenylephrine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 44 503

Cold multi-symptom severe acetaminophen 325 mg / dextromethorphan 10 mg / guaifenesin 200 mg / phenylephrine 5 mg 44 503

Cold Multi-Symptom Severe

Generic Name
acetaminophen/dextromethorphan/guaifenesin/phenylephrine
Imprint
44 503
Strength
acetaminophen 325 mg / dextromethorphan 10 mg / guaifenesin 200 mg / phenylephrine 5 mg
Color
Yellow
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Upper respiratory combinations
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Stephen L. LaFrance Pharmacy, Inc.
National Drug Code (NDC)
15127-0962
Inactive Ingredients
D&C Yellow No. 10, magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glycol, stearic acid, sucralose, titanium dioxide, magnesium silicate, corn starch

Note: Inactive ingredients may vary.

Submitted by: Drugs.com

Get help with Imprint Code FAQs.

More about Cold Multi-Symptom Severe (acetaminophen / dextromethorphan / guaifenesin / phenylephrine)

Consumer resources

Other brands: Vicks DayQuil Severe Cold & Flu, Tylenol Cold & Flu Severe, Sudafed PE Cold & Cough, Decorel Forte Plus, ... +6 more

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.